Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281779080> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4281779080 endingPage "e23544" @default.
- W4281779080 startingPage "e23544" @default.
- W4281779080 abstract "e23544 Background: Soft tissue sarcomas (STS) are a rare heterogeneous group of neoplasms that count for less than one percent of all solid cancers in adults. There is limited data from Saudi Arabia (SA). We aimed to describe the disease characteristics and clinical outcome of STS from a specialized referral center in STS management in SA. Methods: All adult patients treated at King Faisal Specialist Hospital and Research Center between January 2010 and December 2019 were reviewed. Continuous variables are described in median and interquartile range, and categorical variables are described in frequency and compared by the Chi-square test. Survival analysis was estimated by the Kaplan-Meier method and compared by the Log-Rank test. Results: Two hundred fourteen patients diagnosed with soft tissue sarcoma were eligible for the study. The median age at diagnosis was 38 years old (IQR: 26-50.5), and males were (56.1%). The most common histology subtypes were synovial sarcoma (19.6%), liposarcoma (13.5%), undifferentiated pleomorphic sarcoma (11.6%), leiomyosarcoma (9.8%). The most common presentation was painless swelling (49.1%), and the median duration of symptoms was 8 (IQR: 4–13) months. The majority (131 patients, 61.2%) were localized diseases, and the most common primary site was the lower limb (62.1%). The median tumor size was 10 (IQR: 6.8-15) cm, and the tumors were deep to fascia in 144 (67.3%) patients. Eighty-three patients (38.8%) presented with de novo metastasis, and lung (81.9%) was the most common site. The local therapy was as follows; surgery (45.3%), radiation (7.5%), both (41.6%), and none (5.6%). Eighty-five patients received chemotherapy as follows; anthracycline (51%), ifosfamide (28%), and both (23.5%). Seventy-nine patients (36.9%) achieved complete response, 56 (26.2%) developed distant metastasis, and 11 (5.1%) local relapse. Thirty-one patients received salvage chemotherapy, and 30 patients received second-line chemotherapy. The best response of first-line chemotherapy in metastatic patients was CR (3%), PR (14%), SD (8%), and PD (63%). The median follow-up was 37 (IQR: 12-76.75) months. The median OS for the localized disease was not reached, and three years OS was 88.2%. There was a statistical difference in OS between extremities vs. trunk (90.9% vs. 66.7%), (p = 0.01), histological subtypes (p = 0.006), nodal involvement (p < 0.001), T stage (p = 0.03), and complete response 96.9 vs. 68.5% (p < 0.001). The median OS for metastatic disease was 26 (95% CI: 16–35.5) months. The median OS for patients who underwent surgery, radiation, both or none were 26, 23, 31, and 9 months, respectively (p = 0.004). Conclusions: STS in SA is diagnosed at a younger age, with a longer median time for diagnosis and a more advanced stage. Histological subtypes and the advantage of local disease control and metastasectomy are consistent with other figures." @default.
- W4281779080 created "2022-06-13" @default.
- W4281779080 creator A5003945064 @default.
- W4281779080 creator A5012446584 @default.
- W4281779080 creator A5017819970 @default.
- W4281779080 creator A5047624373 @default.
- W4281779080 creator A5056151204 @default.
- W4281779080 creator A5063141890 @default.
- W4281779080 creator A5068409126 @default.
- W4281779080 creator A5072134108 @default.
- W4281779080 creator A5077769232 @default.
- W4281779080 creator A5091579721 @default.
- W4281779080 date "2022-06-01" @default.
- W4281779080 modified "2023-09-27" @default.
- W4281779080 title "Characteristics and outcomes of soft tissue sarcoma in Saudi Arabia." @default.
- W4281779080 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.e23544" @default.
- W4281779080 hasPublicationYear "2022" @default.
- W4281779080 type Work @default.
- W4281779080 citedByCount "0" @default.
- W4281779080 crossrefType "journal-article" @default.
- W4281779080 hasAuthorship W4281779080A5003945064 @default.
- W4281779080 hasAuthorship W4281779080A5012446584 @default.
- W4281779080 hasAuthorship W4281779080A5017819970 @default.
- W4281779080 hasAuthorship W4281779080A5047624373 @default.
- W4281779080 hasAuthorship W4281779080A5056151204 @default.
- W4281779080 hasAuthorship W4281779080A5063141890 @default.
- W4281779080 hasAuthorship W4281779080A5068409126 @default.
- W4281779080 hasAuthorship W4281779080A5072134108 @default.
- W4281779080 hasAuthorship W4281779080A5077769232 @default.
- W4281779080 hasAuthorship W4281779080A5091579721 @default.
- W4281779080 hasConcept C119060515 @default.
- W4281779080 hasConcept C136948725 @default.
- W4281779080 hasConcept C141071460 @default.
- W4281779080 hasConcept C142724271 @default.
- W4281779080 hasConcept C2776910622 @default.
- W4281779080 hasConcept C2777532014 @default.
- W4281779080 hasConcept C2777666782 @default.
- W4281779080 hasConcept C2778256501 @default.
- W4281779080 hasConcept C2778629024 @default.
- W4281779080 hasConcept C2779568860 @default.
- W4281779080 hasConcept C2910096961 @default.
- W4281779080 hasConcept C71924100 @default.
- W4281779080 hasConceptScore W4281779080C119060515 @default.
- W4281779080 hasConceptScore W4281779080C136948725 @default.
- W4281779080 hasConceptScore W4281779080C141071460 @default.
- W4281779080 hasConceptScore W4281779080C142724271 @default.
- W4281779080 hasConceptScore W4281779080C2776910622 @default.
- W4281779080 hasConceptScore W4281779080C2777532014 @default.
- W4281779080 hasConceptScore W4281779080C2777666782 @default.
- W4281779080 hasConceptScore W4281779080C2778256501 @default.
- W4281779080 hasConceptScore W4281779080C2778629024 @default.
- W4281779080 hasConceptScore W4281779080C2779568860 @default.
- W4281779080 hasConceptScore W4281779080C2910096961 @default.
- W4281779080 hasConceptScore W4281779080C71924100 @default.
- W4281779080 hasIssue "16_suppl" @default.
- W4281779080 hasLocation W42817790801 @default.
- W4281779080 hasOpenAccess W4281779080 @default.
- W4281779080 hasPrimaryLocation W42817790801 @default.
- W4281779080 hasRelatedWork W1936216083 @default.
- W4281779080 hasRelatedWork W2104214934 @default.
- W4281779080 hasRelatedWork W2318279699 @default.
- W4281779080 hasRelatedWork W2399994201 @default.
- W4281779080 hasRelatedWork W2803808327 @default.
- W4281779080 hasRelatedWork W3030992995 @default.
- W4281779080 hasRelatedWork W3136349265 @default.
- W4281779080 hasRelatedWork W3202572366 @default.
- W4281779080 hasRelatedWork W4225305779 @default.
- W4281779080 hasRelatedWork W4286433171 @default.
- W4281779080 hasVolume "40" @default.
- W4281779080 isParatext "false" @default.
- W4281779080 isRetracted "false" @default.
- W4281779080 workType "article" @default.